Professor Martin Kaiser

Dr Martin Kaiser is a Haematologist.

Dr Kaiser studied medicine at RWTH University Aachen in Germany, where they also obtained their MD. They completed their medical and haematology specialist training at Charité University Hospital in Berlin. Throughout their training, Dr Kaiser undertook translational research in myeloma, lymphoma and acute leukaemia. Their interest in the genetics and epigenetics of myeloma led them to join the Centre for Myeloma Research. Dr Kaiser is a dedicated haemato-oncologist who combines their clinical work with laboratory-based research.

Dr Kaiser is an expert in the clinical management of multiple myeloma and associated plasma cell dyscrasias such as MGUS and amyloidosis. They are involved in several phase I, II and III clinical studies that investigate novel treatment approaches for myeloma. As a clinician scientist, they are keen to understand the biologic principles of myeloma through laboratory research with a focus on translating the findings into diagnostic and therapeutic tools to improve the treatment of patients. Dr Kaiser is involved in developing innovative molecular diagnostic tests which help identify patient subgroups of myeloma that are candidates for specific treatments. Their research regarding the epigenetic features of myeloma aims at identifying potential novel epigenetic therapeutic targets.

Dr Kaiser has authored numerous research articles in peer-reviewed journals and has been a speaker at national and international conferences. They are involved in tissue biobanking for the Myeloma UK trial network as well as for the Myeloma XI trial.